AVITA Medical (RCEL) analyst forecast and price target
Analyst forecast
Consensus of 6 analyst ratings
Based on 3 analyst targets
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Lake Street | Maintained | Buy | $12.00 from $8.00 | Aug 28, 2026 |
| BTIG | Maintained | Buy | $11.00 from $7.00 | Aug 19, 2026 |
| TD Cowen | Maintained | Buy | $14.00 from $12.00 | Aug 19, 2026 |
| BTIG | Upgraded | Neutral → Buy | $7.00 | Aug 7, 2026 |
| Lake Street | Upgraded | Hold → Buy | $6.00 from $3.50 | May 15, 2026 |
| D. Boral Capital | Maintained | Buy | $10.00 | Apr 9, 2026 |
| D. Boral Capital | Maintained | Buy | $10.00 | Apr 8, 2026 |
| Northland Capital Markets | Initiated Coverage | Outperform | $10.00 | Mar 5, 2026 |
| D. Boral Capital | Maintained | Buy | $10.00 | Feb 17, 2026 |
| D. Boral Capital | Maintained | Buy | $10.00 | Jan 26, 2026 |
| Lake Street | Maintained | Hold | $3.50 from $3.00 | Jan 16, 2026 |
| D. Boral Capital | Maintained | Buy | $10.00 from $14.00 | Jan 15, 2026 |
| BTIG | Upgraded | Sell → Neutral | — | Nov 20, 2025 |
| D. Boral Capital | Maintained | Buy | $14.00 | Nov 7, 2025 |
| D. Boral Capital | Maintained | Buy | $14.00 | Oct 17, 2025 |
| Lake Street | Downgraded | Buy → Hold | $4.00 from $8.00 | Oct 17, 2025 |
| D. Boral Capital | Maintained | Buy | $14.00 | Sep 15, 2025 |
| D. Boral Capital | Maintained | Buy | $14.00 from $18.00 | Sep 5, 2025 |
| Lake Street | Maintained | Buy | $8.00 from $14.00 | Aug 11, 2025 |
| D. Boral Capital | Maintained | Buy | $18.00 from $19.00 | Aug 8, 2025 |
Frequently asked questions
What is the price target for RCEL stock?
The average 12-month analyst price target for AVITA Medical (RCEL) is $12.33, with a high estimate of $14.00 and a low of $11.00, across 3 analysts.
Is RCEL a buy, sell, or hold?
Analysts covering AVITA Medical currently average a Buy rating: 5 buy, 1 hold and 0 sell, from 6 analysts. Ratings reflect analyst opinion, not investment advice.
What upside do analysts see for RCEL?
The average price target of $12.33 implies 22.48% upside from the last price of $10.07.
What is the latest analyst rating on RCEL?
On Aug 28, 2026, Lake Street maintained AVITA Medical at Buy with a price target of $12.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.